Shared gene expression alterations in schizophrenia and bipolar disorder

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Schizophrenia (SZ) and bipolar disorder (BPD) affect ~2.5% of the global population.
• Their etiologies involve complex genetic and environmental factors.
• Brain gene expression patterns may offer distinct signatures for SZ and BPD.

Purpose of the Study:

• To identify shared molecular profiles in the brain for SZ and BPD.
• To explore common pathophysiological mechanisms underlying these disorders.
• To discover potential targets for novel therapeutic interventions.

Main Methods:

• RNA samples from dorsolateral prefrontal cortex (Brodmann area 46) of SZ, BPD, and control subjects.
• Gene expression profiling using Codelink Human 20K Bioarray.
• Validation of selected transcripts via quantitative real-time PCR (Q-PCR).
• Statistical control for age, gender, and pH using ANCOVA.

Main Results:

• 78 candidate genes showed significant dysregulation in both SZ and BPD compared to controls.
• Overrepresentation of functional categories: nervous system development, immune response, and cell death.
• Five dysregulated genes confirmed by Q-PCR; AGXT2L1, SLC1A2, and TU3A showed high brain enrichment.
• AGXT2L1 expression significantly differed between controls and SZ/BPD patients (p < 10(-06)).

Conclusions:

• A partially shared molecular profile exists for SZ and BPD.
• These findings provide insights into common pathophysiology.
• This shared profile may facilitate the development of core treatment strategies for both disorders.